Ross Reynolds talks with Dr. Kathy Neuzil about a vaccine for the deadly brain disease Japanese encephalitis that has been recently approved by the World Health Organization. Neuzil is a professor in the University of Washington's Department of Global Health and the director of the Vaccine Access and Delivery Program at Seattle's PATH, where the vaccine was tested.
In the global fight against HIV/AIDS, there's some very good news. According to a new report from the United Nations, the number of new HIV infections are down by nearly one-third over the last decade. Among children new infections are down 52 percent. The number of AIDS-related deaths are also down.
Nyaope is a whitish powder - low-grade heroin mixed with ingredients such as rat poison and sometimes even crushed-up medicine for people with HIV. Sprinkled on top of marijuana, it is a highly addictive, life-wrecking cocktail.
In an open space near the railway in the South African township of Soweto, several young men and women in their early twenties are smoking nyaope, a new drug cocktail. Some look like the walking dead they are so stoned. "I was studying but then I quit because of the drugs.
Why didn’t the TARP bailout fund help the small businesses and homeowners who were slammed by the 2008 financial crash? Neil Barofsky left his job at the US Attorney’s Office in New York to become special inspector general in charge of overseeing the bailout money. He says, from his first days on the job he was met with hostility from the treasury officials overseeing the TARP fund. He charges that Treasury Secretary Timothy Geithner funneled money to Wall Street firms in ways that bordered on corruption. Neil Barofsky joins us with the inside story.
Access to HIV and TB treatment has been improving worldwide. The rate of new infections is going down. But tuberculosis remains deadly, especially for the poverty stricken — TB killed 1.4 million people in 2011. Luwiza Makukula was diagnosed with HIV and TB after her husband died in 2001. Not only was she sick, she was completely isolated. Today, she works with NGOs focused on treatment, care, and support for HIV/TB patients, including Zambia's Community Initiative for TB, HIV/AIDS and Malaria (CITAM+). Luwiza Makukula joins us.